ENTITY
Celltrion Healthcare

Celltrion Healthcare (091990 KS)

216
Analysis
Health Care • South Korea
Celltrion Healthcare Co.,Ltd develops and manufactures pharmaceutical biologics and chemically synthesized drugs. The Company specializes in the development of drugs for breast cancer, arthritis, leukemia, psoriasis, human rabies prevention, and influenza. Celltrion Healthcare markets its products to customers internationally.
more
bullish•Celltrion Inc
•02 Nov 2023 05:40

Celltrion Merger: Appraisal Rights & Passive Flows

The appraisal rights exercise period ends 13 Nov. Both companies are buying back shares. The last traded price is close to the appraisal price....

Logo
676 Views
Share
•01 Nov 2023 07:00

(Mostly) Asia M&A, Oct 2023: Haitong, Azure, Hollysys, Aeon, Teraoka, Tietto, Lithium Power

For the month of October, 7 new deals were discussed on Smartkarma with an overall deal size of ~US$4bn. The average premium for the new deals...

Logo
540 Views
Share
bullish•JSR Corp
•30 Oct 2023 02:01

Merger Arb Mondays (30 Oct) - JSR, Eoflow, Azure Minerals, Symbio, Hollysys, Haitong Intl

This week, the highest gross spreads are 111 (71.8%), Eoflow (38.2%), Hollysys (22.4%), Symbio (10.1%), JSR (9.3%), Healius (8.9%), Haitong Intl...

Logo
853 Views
Share
bullish•Newcrest Mining
•29 Oct 2023 07:05

Last Week In Event SPACE: Newcrest/Newmont, Keisei Electric, PCCW, Cosmo Energy, Leapmotor

The weekend is here! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed...

Logo
747 Views
Share
bullish•Eoflow
•29 Oct 2023 07:00

(Mostly) Asia-Pac Weekly Risk Arb Wrap: Azure, EOFlow, Hollysys, Essential Metals, Celltrion Health

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
649 Views
Share
x